1. Home
  2. ARVN vs NAVI Comparison

ARVN vs NAVI Comparison

Compare ARVN & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.13

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$8.05

Market Cap

771.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
NAVI
Founded
2015
1973
Country
United States
United States
Employees
N/A
670
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
781.0M
771.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ARVN
NAVI
Price
$10.13
$8.05
Analyst Decision
Buy
Sell
Analyst Count
20
7
Target Price
$15.35
$12.14
AVG Volume (30 Days)
670.7K
844.6K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
7.78%
EPS Growth
58.84
N/A
EPS
N/A
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$74.32
Revenue Next Year
N/A
$15.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$7.86
52 Week High
$14.22
$16.07

Technical Indicators

Market Signals
Indicator
ARVN
NAVI
Relative Strength Index (RSI) 31.91 30.14
Support Level $9.02 $7.86
Resistance Level $10.18 $8.40
Average True Range (ATR) 0.67 0.24
MACD -0.22 0.09
Stochastic Oscillator 4.18 33.33

Price Performance

Historical Comparison
ARVN
NAVI

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

Share on Social Networks: